Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.

Garaci, E

Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells. [electronic resource] - Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy Jan 1993 - 7-17 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1067-5582

10.1097/00002371-199301000-00002 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
CD4 Antigens--immunology
CD8 Antigens--immunology
Cyclophosphamide--administration & dosage
Cytotoxicity, Immunologic--drug effects
Disease Models, Animal
Friend murine leukemia virus
G(M1) Ganglioside--immunology
Interferon-alpha--administration & dosage
Interferon-beta--administration & dosage
Interleukin-2--administration & dosage
Leukemia, Erythroblastic, Acute--mortality
Leukemia, Experimental--prevention & control
Male
Mice
Mice, Inbred DBA
Thymalfasin
Thymosin--administration & dosage
Tumor Virus Infections--prevention & control